The StockTalk Cannabis Report: Apr 23, 2021

This Cannabis Co. Earned a 100% Revenue Increase Over 3 Consecutive Quarters



Avicanna Inc. is a diversified and vertically integrated Canadian biopharmaceutical Company that is focused on the research, development, and commercialization of plant-derived cannabinoid-based products for the global consumer, medical, and pharmaceutical market segments. In this video, Avicanna’s Chief Executive Officer, Aras Azadian, offers a corporate update for shareholders, dicing into his company’s recent efforts to develop, manufacture, and commercialize plant-derived cannabinoid-based products for its pharmaceutical pipeline.

Read the Full Story Here

Weekly Update - Top Cannabis News Stories

1 | Top Story: A ‘Novel’ investment in psychedelic-inspired medicines. A Stockhouse exclusive CEO interview.

2 | Canopy Growth Corp. partners with American alcohol beverage distribution giant Southern Glazer's Wine & Spirits

3 | Cannabis CPG Multi-State Operator, BellRock Brands Inc., secures financing of up to USD$4 million.

4 | BevCanna Enterprises Inc’s Naturo Group signs exclusive distribution agreement for TRACE in Japan and Philippines.

5 | Tilray Inc. to extends deadline vote on Aphria deal; amends bylaws for quorum requirements.

1. T.APHA | 61,099 views | Aphria Inc.
2. T.HEXO | 38,911 views | HEXO Corp.
3. T.WEED | 28,823 views | Canopy Growth Corp.
4. T.AH | 23,914 views | Aleafia Health Inc.
5. C.CBDT | 21,686 views | Empower Clinics Inc.
6. T.VLNS | 12,204 views | Valens Company Inc.

FULL DISCLOSURE: Avicanna Inc. and Mindset Pharma Inc. are clients of Stockhouse Publishing.

New to investing in Cannabis? Check out Stockhouse tips on How to Invest in Cannabis Stocks and some of our Top Cannabis Stocks.

For more of the latest info on Cannabis, check out the Cannabis Trending News hub on Stockhouse.